Sectors
TLSI
TriSalus Life Sciences, Inc.
4.95
2 x 3.39
2 x 5.72
bid
ask
+
0.12
2.48%
2 @ 07:30 PM
4.95 +0.00 (0.00%)
| Ytd | -29.08% | |
| 1y | -5.17% |
4.81
day range
5.03
2.20
52 week range
7.95
| Open | 4.85 | Prev Close | 4.83 | Low | 4.81 | High | 5.03 | Mkt Cap | 304.79M |
| Vol | 72.69K | Avg Vol | 303.84K | EPS | -1.36 | P/E | N/A | Forward P/E | -3.50 |
| Beta | 0.50 | Short Ratio | 2.38 | Inst. Own | 17.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 4.65 | 200-d Avg | 4.82 | 1yr Est | 11.64 |
| Income Statement | |||
| Total Revenue | 11.41M | ||
| Revenues (USD) | 11.41M | ||
| Cost of Revenue | 1.51M | ||
| Gross Profit | 9.90M | ||
| Operating Expenses | 19.71M | ||
| Research and Development Expense | 3.14M | ||
| Selling, General and Administrative Expense | 16.58M | ||
| Operating Income | -9.81M | ||
| Interest Expense | 1.49M | ||
| Income Tax Expense | 4.00K | ||
| Net Income | -9.19M | ||
| Net Income Common Stock | -9.19M | ||
| Net Income Common Stock (USD) | -9.19M | ||
| Consolidated Income | -9.19M | ||
| Earnings per Basic Share | -0.16 | ||
| Earnings per Basic Share (USD) | -0.16 | ||
| Earnings per Diluted Share | -0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -7.69M | ||
| Earning Before Interest & Taxes (USD) | -7.69M | ||
| Weighted Average Shares | 58.30M | ||
| Weighted Average Shares Diluted | 58.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 46.29M | ||
| Cash and Equivalents (USD) | 46.29M | ||
| Trade and Non-Trade Receivables | 6.46M | ||
| Current Assets | 59.74M | ||
| Property, Plant & Equipment Net | 2.64M | ||
| Total Assets | 62.45M | ||
| Debt Current | 244.00K | ||
| Total Debt | 34.43M | ||
| Current Liabilities | 11.17M | ||
| Debt Non-Current | 34.18M | ||
| Total Liabilities | 55.90M | ||
| Accumulated Retained Earnings (Deficit) | -338.23M | ||
| Shareholders Equity | 6.55M | ||
| Shareholders Equity (USD) | 6.55M | ||
| Assets Non-Current | 2.70M | ||
| Total Debt (USD) | 34.43M | ||
| Inventory | 4.21M | ||
| Liabilities Non-Current | 44.73M | ||
| Trade and Non-Trade Payables | 3.76M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 167.00K | ||
| Net Cash Flow from Financing | -54.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.26M | ||
| Capital Expenditure | -82.00K | ||
| Issuance (Purchase) of Equity Shares | 287.00K | ||
| Issuance (Repayment) of Debt Securities | -368.00K | ||
| Net Cash Flow from Investing | -82.00K | ||
| Net Cash Flow from Operations | -10.13M | ||
| Share Based Compensation | 2.62M | ||